MIR6832

Across TCGA pan-cancer cohorts, MIR6832 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated MIR6832 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher MIR6832 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR6832 expression acts as an unfavorable survival marker, although some lineages such as PAAD and STAD show a favorable association.

KIRC, PAAD, and UVM are the cancer types where MIR6832 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Median	All	0.520	0.708	<.001	130	view →
PAAD	DFS	Median	All	0.601	0.375	<.001	66	view →
UVM	DFS	Median	III,IV	0.309	0.749	<.001	60	view →
COAD	OS	Median	All	0.823	0.902	.003	53	view →
STAD	OS	Median	III,IV	0.776	0.480	<.001	35	view →
PRAD	DFS	Median	All	0.706	0.827	<.001	32	view →
DLBC	DFS	Tertile	II,III,IV	0.476	1.000	.005	29	view →
PCPG	OS	Median	All	0.627	1.000	.005	23	view →
THCA	OS	Median	III,IV	0.879	0.967	.005	20	view →
LIHC	DFS	Median	III,IV	0.386	0.108	.005	20	view →
LGG	DFS	Quartile	All	0.750	0.859	<.001	19	view →
BRCA	OS	Quartile	All	0.722	0.553	.013	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

MIR6832–KIRC (OS)

Open the KIRC breakdown →